The Changing Environment for Pharma and Medtech Companies in Europe

Basel, Switzerland, September 30, 2013 --(PR.com)-- On 8 October 2013, SFL will hold an event at the Institute of Directors, London entitled “The Changing Environment for Pharma and Medtech Companies in Europe.”

SFL’s cross-functional experts will share their perspectives on key developments in the sector’s regulatory and legal framework:

- impact on development and maintenance of medicinal products and devices
- impact on interaction with healthcare professionals

This evening event will be of interest to both experienced professionals from pharmaceutical and medtech companies and others interested in the operating environment for healthcare industries. Following the presentations and a Q&A session there will be a further opportunity to network with speakers and other colleagues over canapés and drinks.

Please contact the company for further information.

About SFL Regulatory Affairs & Scientific Communication Ltd:
SFL is dedicated to a holistic approach to lifecycle management of healthcare products. The SFL team works from offices in Switzerland and the United Kingdom, Europe’s key locations for healthcare products development. At SFL we provide integrated solutions from the bench to approval and reimbursement within one consultancy, with expertise in Regulatory Affairs, Public Affairs, Legal Services, Medical Communication, HTA, Pricing and Reimbursement. We conduct portfolio analyses and provide strategic support for products in diverse therapeutic areas. In our deliveries, we also consider ethical aspects of appropriate values, norms and principles.